# A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia

> **NCT07061145** · — · RECRUITING · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 350 (estimated)

## Conditions studied

- Chronic Myelocytic Leukemia
- Erectile Dysfunctions
- CVD - Cardiovascular Disease
- Tyrosine Kinase Inhibitor

## Interventions

- **DRUG:** Tirosin Kinase Inhibitors

## Key facts

- **NCT ID:** NCT07061145
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2028-12
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07061145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07061145, "A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07061145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*